Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
The report details the trend, potential and market size of Insulin Glargine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Insulin Glarginemarket, defines the market attractiveness level of Insulin Glargine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Insulin Glargine industry, describes the types of Insulin Glargine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin Glargine market and the development prospects and opportunities of Insulin Glargine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin Glargine market in Chapter 13.
By Player:
Ganlee
Sanofi-Aventis
Biocon
By Type:
Single Dose Vial
Pre-filled Syringe
By End-User:
Treat type2 diabetes
Treat type1 diabetes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Insulin Glargine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Insulin Glargine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Insulin Glargine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Insulin Glargine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Insulin Glargine Market Analysis and Outlook to 2022
-
7.1 Global Insulin Glargine Consumption (2017-2022)
-
7.2 United States Insulin Glargine Consumption (2017-2022)
-
7.3 Europe Insulin Glargine Consumption (2017-2022)
-
7.4 China Insulin Glargine Consumption (2017-2022)
-
7.5 Japan Insulin Glargine Consumption (2017-2022)
-
7.6 India Insulin Glargine Consumption (2017-2022)
-
7.7 South Korea Insulin Glargine Consumption (2017-2022)
8 Region and Country-wise Insulin Glargine Market Analysis and Outlook to 2028
-
8.1 Global Insulin Glargine Consumption Forecast (2022-2028)
-
8.2 United States Insulin Glargine Consumption Forecast (2022-2028)
-
8.3 Europe Insulin Glargine Consumption Forecast (2022-2028)
-
8.4 China Insulin Glargine Consumption Forecast (2022-2028)
-
8.5 Japan Insulin Glargine Consumption Forecast (2022-2028)
-
8.6 India Insulin Glargine Consumption Forecast (2022-2028)
-
8.7 South Korea Insulin Glargine Consumption Forecast (2022-2028)
9 Global Insulin Glargine Market Outlook by Types and Applications to 2022
-
9.1 Global Insulin Glargine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Single Dose Vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)
-
9.2 Global Insulin Glargine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Treat type2 diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Treat type1 diabetes Consumption and Growth Rate (2017-2022)
10 Global Insulin Glargine Market Outlook by Types and Applications to 2028
-
10.1 Global Insulin Glargine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Insulin Glargine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Treat type2 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Treat type1 diabetes Consumption Forecast and Growth Rate (2022-2028)
11 Global Insulin Glargine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Insulin Glargine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Insulin Glargine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Insulin Glargine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Insulin Glargine Market Competitive Analysis
-
14.1 Ganlee
-
14.1.1 Ganlee Company Details
-
14.1.2 Ganlee Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ganlee Insulin Glargine Product and Service
-
14.2 Sanofi-Aventis
-
14.2.1 Sanofi-Aventis Company Details
-
14.2.2 Sanofi-Aventis Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi-Aventis Insulin Glargine Product and Service
-
14.3 Biocon
-
14.3.1 Biocon Company Details
-
14.3.2 Biocon Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biocon Insulin Glargine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Insulin Glargine
-
Figure Insulin Glargine Picture
-
Table Global Insulin Glargine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Glargine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Glargine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Insulin Glargine Consumption by Country (2017-2022)
-
Figure United States Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Table Europe Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure China Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure Japan Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure India Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Glargine Consumption Forecast by Country (2022-2028)
-
Figure United States Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single Dose Vial Consumption and Growth Rate (2017-2022)
-
Figure Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)
-
Figure Global Treat type2 diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Treat type1 diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treat type2 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treat type1 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Insulin Glargine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Insulin Glargine Export by Region (Top 5 Countries) (2017-2028)
-
Table Ganlee (Foundation Year, Company Profile and etc.)
-
Table Ganlee Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ganlee Insulin Glargine Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Insulin Glargine Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Insulin Glargine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Insulin Glargine Product and Service
-
